Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of drospirenone + ethinyl estradiol tablets relative to YAZ in healthy Thai female volunteers under fasting conditions
TCTR20211215004Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ethinyl estradiol + drospirenone in contraception (2 arms), sponsored by Bio-innova. Primary endpoint: Primary pharmacokinetic bioequivalence endpoints. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on TCTR20211215004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211215004.